Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Judah Greenberg

Dermatology Macon, GA Medical Doctor

NPI 1124288790 CMS profile 3108877

308 Coliseum Dr Ste 200, Macon, GA 31217

Open in the dashboard

General payments

$3,700

212 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Judah Greenberg of Macon, GA is reported in the CMS Open Payments database as having received $3,700 across 212 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 58th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $210 5
2024 General $82 4
2023 General $601 34
2022 General $717 43
2021 General $988 66
2020 General $363 20
2019 General $739 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Judah Greenberg
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Judah Greenberg were reported at $210. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Judah Greenberg Dermatology median Middle half National median
2019 $739 $454 $129–$1,240 $163
2020 $363 $235 $81–$756 $114
2021 $988 $377 $108–$1,108 $132
2022 $717 $514 $143–$1,391 $149
2023 $601 $607 $159–$1,674 $160
2024 $82 $751 $204–$1,903 $164
2025 $210 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,803 111 payments
  2. Novartis Pharmaceuticals Corporation $424 29 payments
  3. Janssen Biotech, Inc. $374 26 payments
  4. Kerecis Limited $166 2 payments
  5. Pfizer Inc. $158 9 payments
  6. Allergan Inc. $131 2 payments
  7. Arcutis Biotherapeutics, Inc. $109 2 payments
  8. LEO Pharma Inc. $79 5 payments
  9. Amgen Inc. $77 4 payments
  10. Genzyme Corporation $62 3 payments
  11. Other $317 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,510 210 payments
  2. Education $190 2 payments
Products named General payments · program years 2019–2025
  1. SKYRIZI $1,242 86 payments
  2. HUMIRA $480 24 payments
  3. RINVOQ $374 18 payments
  4. TREMFYA $360 25 payments
  5. COSENTYX Immunology $216 13 payments
  6. EUCRISA $158 9 payments
  7. COSENTYX Dermatology $142 13 payments
  8. Kerecis SurgiClose Wound Care $132 1 payment
  9. Kerecis GraftGuide $132 1 payment
  10. Kerecis SurgiClose Wound Care $132 1 payment
  11. Other $1,276 56 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

308

Median for Dermatology: 534

Drug cost

$3,269

Median for Dermatology: $67,151

Branded share of claims

6.2%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Hyclate Generic 135 $1,193
Clobetasol Propionate Generic 24 $906
Ketoconazole Generic 49 $552
Mupirocin Generic 40 $281
Triamcinolone Acetonide Generic 21 $251
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 19 $58
Cephalexin Generic 20 $28

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 57 billing codes

Paid by Medicare

$227,050

Medicare's payments for the services billed

Medicare patients

271

Average age 77

Services billed

938

84 women, 187 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 38%
Ischemic heart disease 31%
Chronic kidney disease 31%
Diabetes 27%
Atrial fibrillation 17%
Cancer 16%
Depression 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
RINVOQ
  • AbbVie, Inc. $23
$23 — —
Bimzelx
  • UCB, Inc. $23
$23 — —
COSENTYX
  • Novartis Pharmaceuticals Corporation $19
$19 — —
SKYRIZI
  • AbbVie, Inc. $17
$17 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

212 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record